Protocol summary

Summary
Objectives: To determine pregnancy rate after comprehensive chromosome screening (CCS) using PGD NGS in frozen embryo transfer cycles after blastocyst’s trophoectoderm biopsy. Design: Prospective study. Setting: A private centers for reproductive medicine. Material and methods: 40 patients who will decide to undergo PGD on 24 chromosomes on blastocystes with vitrification and frozen embryo transfer will be included in the study as a investigated group. A control group was adjusted according to anti-Müllerian hormone level (AMH) and antral follicle count (AFC). This group included 34 cases in whom a fresh cycle transfer was postponed for several reasons: progesterone > 2.0 ng / ml on the day of hCG administration (n = 16); endometrial thickness <6 mm on the day of hCG administration (n = 9); and a risk of ovarian hyperstimulation syndrome (OHSS) (n = 9) with qualification for FET cycle; this group involved frozen blastocysts without PGD transfer. Intervention(s): Choice of the embryos for transfer based on the PGD NGS results. Main Outcome Measure(s): Clinical pregnancy rate (PR) per embryo transfer will be our primary outcome. Secondary outcome will be the implantation rate.

General information

Acronym
IRCT registration information
IRCT registration number: IRCT2014062318202N1
Registration date: 2014-07-10, 1393/04/19
Registration timing: prospective

Last update:
Update count: 0
Registration date
2014-07-10, 1393/04/19
Registrant information
Name
Judyta Zabielska
Name of organization / entity
Invicta Sp.z o.o.
Country
Poland
Phone
0048 516 829 691
Email address
zabielska@gumed.edu.pl
Recruitment status
Recruitment complete
Funding source
Funded by Invicta s.z o.o.
Expected recruitment start date
2014-08-01, 1393/05/10
Expected recruitment end date
2014-09-01, 1393/06/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The impact of next generation sequencing (NGS) preimplantation genetic diagnostics (PGD) on pregnancy rate of frozen blastocyst embryo transfer.
Public title
The impact of next generation sequencing (NGS) preimplantation genetic diagnostics (PGD) on pregnancy rate of frozen blastocyst embryo transfer.
Purpose
Diagnostic
Inclusion/Exclusion criteria
Incusion: 1. Patients undergoing assisted reproductive treatment with intracytoplasmic sperm injection and frozen blastocyst embryotransfer in Invicta Fertility and Reproductive Centre s. z o.o. in time frame from 08.2014 to 09.2014 Exclusion: 1. Blastocysts in stages 2CC, 3CC, 4CC, and 5CC did not qualify for biopsy. 2.Patients in whom no normal embryo was available
Age
From 33 years old to 42 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size: 32
Randomization (investigator's opinion)
Not randomized
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Komisja Bioetyczna przy Okręgowej Izbie Lekarskiej
Street address
ul. Śniadeckich 33
City
Gdańsk
Postal code
80-214
Approval date
2014-05-20, 1393/02/30
Ethics committee reference number
KB 12/14

Health conditions studied

1

Description of health condition studied
Infertility
ICD-10 code
N97.9
ICD-10 code description
Female infertility, unspecified

Primary outcomes

1

Description
pregnancy rate
Timepoint
on 6 weeks and 1-3 days
Method of measurement
clinical poregnancy (as ultrasound fetal heartbeat detection)

Secondary outcomes

1

Description
implantation rate
Timepoint
7 day after tansfer
Method of measurement
blood serum beta-HCG concentration

Intervention groups

1

Description
Next Generation Sequencing Preimplantation Genetic Diagnosis embryo selection
Category
Diagnosis

Recruitment centers

1

Recruitment center
Name of recruitment center
Invicta Fertility and Reproductive Centre
Full name of responsible person
Judyta Zabielska
Street address
GPNT ul. Trzy lipy 3
City
Gdańsk

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Invicta s.z o.o.
Full name of responsible person
Jolanta Jabłońska
Street address
ul. Trzy lipy 3
City
Gdańsk
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Invicta s.z o.o.
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Invicta Gdańsk
Full name of responsible person
Judyta Zabielska
Position
assistant
Other areas of specialty/work
Street address
ul. Trzy lipy 3
City
Gdańsk
Province
Pomorskie
Postal code
80-172
Phone
0048585858800
Fax
Email
judyta.zabielska@invicta.pl
Web page address
invicta.pl

Person responsible for scientific inquiries

Contact
Name of organization / entity
Invicta Fertility and Reproductive Centre
Full name of responsible person
Judyta Zabielska
Position
assistant
Other areas of specialty/work
Street address
GPNT ul. Trzy lipy 3
City
Gdańsk
Province
Pomorskie
Postal code
80-172
Phone
0048585858800
Fax
Email
judyta.zabielska@invicta.pl
Web page address
invicta.pl

Person responsible for updating data

Contact
Name of organization / entity
Invicta Fertility and Reproductive Centre
Full name of responsible person
Judyta Zabielska
Position
assistant
Other areas of specialty/work
Street address
GPNT, ul. Trzy lipy 3
City
Gdańsk
Province
Pomorskie
Postal code
80-172
Phone
0048585858800
Fax
Email
judyta.zabielska@invicta.pl
Web page address
invicta.pl

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...